The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective agnostic germline testing in pediatric cancer patients.
 
Elise Fiala
No Relationships to Disclose
 
Jennifer Kennedy
No Relationships to Disclose
 
Yelena Kemel
No Relationships to Disclose
 
Audrey Mauguen
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
Ahmet Zehir
Honoraria - Illumina
 
Ozge Birsoy
No Relationships to Disclose
 
Nancy Bouvier
No Relationships to Disclose
 
Anna Maio
No Relationships to Disclose
 
Alicia Latham
Other Relationship - Conquer Cancer Foundation
 
Maria Isabel Carlo
Consulting or Advisory Role - Pfizer
Other Relationship - Prostate Cancer Foundation; Robert Wood Johnson Foundation
 
Karen Anne Cadoo
Honoraria - OncLive
Consulting or Advisory Role - GlaxoSmithKline/Tesaro
Research Funding - AstraZeneca (Inst); Syndax (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Alimera Sciences (I); Allergan (I); Biomarin (I); Fortress Biotech (I); Genentech/Roche (I); Novartis (I); Optos (I); Regeneron (I); Regenxbio (I); Spark Therapeutics (I)
 
Mark E. Robson
Honoraria - AstraZeneca
Consulting or Advisory Role - Change HealthCare
Research Funding - Abbvie (Inst); AstraZeneca (Inst); InVitae (Inst); Medivation (Inst); Myriad Genetics (Inst); Pfizer (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
Other Relationship - Clinical Care Options; Physicans' Education Resource; Research to Practice
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo; Merck; Pfizer
 
Neerav Narendra Shukla
No Relationships to Disclose
 
Stephen S. Roberts
No Relationships to Disclose
 
Andrew Kung
Stock and Other Ownership Interests - Imago Pharma; Isabl Technologies
Consulting or Advisory Role - DarwinHealth; Emendo; Imago Pharma; Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Royalty from licensing agreements with MI Bioresearch
 
Kenneth Offit
Patents, Royalties, Other Intellectual Property - Diagnosis and treatment of ERCC3-mutantcancer;inventors: Vijai Joseph, Sabine Topka, Kenneth Of?t; US National Stage Patent Application No.: 16/493,214; ?ling date: September 11, 2019 (Inst)
 
Michael Francis Walsh
No Relationships to Disclose